PNK-CAR38

N/A

Report date: 2022/09/06 09:43:21

Base Information

Drug NamePNK-CAR38

Drug Alias NamePNK-CAR38

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionAnti-CD38

TargetsLymphocyte differentiation antigen CD38

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelularity Inc

China Registration ClassN/A

Active CompaniesCelularity Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A